Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E van der Ende

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|February 27, 1999
[CD4+-T-cells are the predominant source of HIV-1 and HIV-2 production in asymptomatic people and AIDS patients with opportunistic infections]M E van der Ende, M Schutten, P Racz, et al.
AIDS (London, England)|December 1, 1996
HIV-2 infection in 12 European residents: virus characteristics and disease progressionM E van der Ende, M Schutten, T D Ly, et al.
AIDS (London, England)|December 1, 1994
Cryptococcal meningitis in HIV-infected patientsA C Leenders, M E van der Ende, T C van der Ree, et al.
Transplantation|November 7, 1999
Cyclosporine and triple-drug treatment with human immunodeficiency virus protease inhibitorsP J Gregoor, T van Gelder, M E van der Ende, et al.
Infection|November 1, 1992
Failure of antiviral therapy in AIDS-associated cytomegalovirus cholangitisM E van der Ende, A C van Buuren, A C Kroes, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 24, 2004
[Highly active antiretroviral therapy (HAART) in HIV-positive pregnant women in the Netherlands, 1997-2003: safe, effective and with few side effects]C Tempelman, S Timmermans, M H Godfried, et al.
AIDS (London, England)|April 10, 1999
Urological complaints in relation to indinavir plasma concentrations in HIV-infected patientsJ P Dieleman, I C Gyssens, M E van der Ende, et al.
AIDS (London, England)|August 17, 1999
Substituting nevirapine for protease inhibitors because of intoleranceJ P Dieleman, I C Gyssens, M J Sturkenboom, et al.
Journal of Virology|June 17, 1998
Coreceptor usage of human immunodeficiency virus type 2 primary isolates and biological clones is broad and does not correlate with their syncytium-inducing capacitiesC Guillon, M E van der Ende, P H Boers, et al.
Infection|September 8, 2001
Papillary necrosis associated with the HIV protease inhibitor indinavirJ P Dieleman, M van der Feltz, C H Bangma, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Nederlands Tijdschrift Voor Geneeskunde|February 27, 1999
[CD4+-T-cells are the predominant source of HIV-1 and HIV-2 production in asymptomatic people and AIDS patients with opportunistic infections]M E van der Ende, M Schutten, P Racz, et al.
AIDS (London, England)|December 1, 1996
HIV-2 infection in 12 European residents: virus characteristics and disease progressionM E van der Ende, M Schutten, T D Ly, et al.
AIDS (London, England)|December 1, 1994
Cryptococcal meningitis in HIV-infected patientsA C Leenders, M E van der Ende, T C van der Ree, et al.
Transplantation|November 7, 1999
Cyclosporine and triple-drug treatment with human immunodeficiency virus protease inhibitorsP J Gregoor, T van Gelder, M E van der Ende, et al.
Infection|November 1, 1992
Failure of antiviral therapy in AIDS-associated cytomegalovirus cholangitisM E van der Ende, A C van Buuren, A C Kroes, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 24, 2004
[Highly active antiretroviral therapy (HAART) in HIV-positive pregnant women in the Netherlands, 1997-2003: safe, effective and with few side effects]C Tempelman, S Timmermans, M H Godfried, et al.
AIDS (London, England)|April 10, 1999
Urological complaints in relation to indinavir plasma concentrations in HIV-infected patientsJ P Dieleman, I C Gyssens, M E van der Ende, et al.
AIDS (London, England)|August 17, 1999
Substituting nevirapine for protease inhibitors because of intoleranceJ P Dieleman, I C Gyssens, M J Sturkenboom, et al.
Journal of Virology|June 17, 1998
Coreceptor usage of human immunodeficiency virus type 2 primary isolates and biological clones is broad and does not correlate with their syncytium-inducing capacitiesC Guillon, M E van der Ende, P H Boers, et al.
Infection|September 8, 2001
Papillary necrosis associated with the HIV protease inhibitor indinavirJ P Dieleman, M van der Feltz, C H Bangma, et al.
Pageof 7